Experienced in Chickenpox

Fengcai C. Zhu

No. 305 East Zhongshan Rd, 
Nanjing, CN 
Experienced in Chickenpox
No. 305 East Zhongshan Rd, 
Nanjing, CN 
OverviewLocationsClinical Research

Overview

Fengcai Zhu practices in Nanjing, China. Zhu is rated as an Experienced expert by MediFind in the treatment of Chickenpox. Their top areas of expertise are Severe Acute Respiratory Syndrome (SARS), Herpangina, COVID-19, and Flu.

Their clinical research consists of co-authoring 207 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Chickenpox.

Locations

No. 305 East Zhongshan Rd, Nanjing, 210002, China
Other Locations
Jiangsu Road, Nanjing, 210009, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Single-center, Randomized, Double-blind, Placebo-controlled Phase I/II Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of Recombinant COVID-19 Vaccine (Sf9 Cells) in Healthy People Aged 6-17 Years
Single-center, Randomized, Double-blind, Placebo-controlled Phase I/II Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of Recombinant COVID-19 Vaccine (Sf9 Cells) in Healthy People Aged 6-17 Years
Enrollment Status: Withdrawn
Publish Date: March 28, 2025
Intervention Type: Other, Biological
Study Phase: Phase 1/Phase 2
A Single-center, Randomized, Double-Blinded, Placebo-Controlled, Phase Ⅱ Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells), in the Subjects From Healthy Aged 18 Years and Above
A Single-center, Randomized, Double-Blinded, Placebo-Controlled, Phase Ⅱ Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells), in the Subjects From Healthy Aged 18 Years and Above
Enrollment Status: Completed
Publish Date: June 01, 2022
Intervention Type: Biological
Study Drug: COVID-19 Vaccine
Study Phase: Phase 2
Safety, Tolerability and Immunogenicity of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell) in Chinese Healthy Population Aged 18 Years and Older: A Phase I, Single-center, Randomized, Placebo-controlled, Double-blind Study
Safety, Tolerability and Immunogenicity of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell) in Chinese Healthy Population Aged 18 Years and Older: A Phase I, Single-center, Randomized, Placebo-controlled, Double-blind Study
Enrollment Status: Completed
Publish Date: June 01, 2022
Intervention Type: Biological
Study Phase: Phase 1
A Single-center, Randomized, Double-Blinded, Placebo-Controlled, Phase Ⅱb Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells), in the Subjects From Healthy Aged 18 to 85 Years Old
A Single-center, Randomized, Double-Blinded, Placebo-Controlled, Phase Ⅱb Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells), in the Subjects From Healthy Aged 18 to 85 Years Old
Enrollment Status: Withdrawn
Publish Date: May 25, 2021
Intervention Type: Biological
Study Phase: Phase 2
View 3 Less Clinical Trials

207 Total Publications

Research methods of vaccination coverage and their application in evaluating vaccine protective effectiveness
Research methods of vaccination coverage and their application in evaluating vaccine protective effectiveness
Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
Published: September 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zhu's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 29 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile